Aptevo Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Aptevo Therapeutics Inc. (APVO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.38 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.38M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.38M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.38M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.15M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2025-12-31 | $1.38M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $1.38M 10-K · filed 2025-02-14 | |
| 2023-12-31 | $1.38M 10-K · filed 2024-03-05 | |
| 2022-12-31 | $1.15M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.29M 10-K · filed 2022-03-24 | $1.39M 10-K · filed 2021-03-31 |
| 2019-12-31 | $1.48M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |